BioNTech SE (BNTX) Capital Expenditures Growth (1y) (2019 - 2026)
Powered by 
Analysis
BioNTech SE (BNTX) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -22.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 9.68% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1,133.33% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -37.81% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 142.64% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 22,433.30% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -73.62% |
| 10 | BioNTech SE | 25.06 Bn | 11.41 Bn | 10.00 Mn | -106.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -106.89% |
| Mar 31, 2026 | -29.28% |
| Dec 31, 2025 | -3.37% |
| Sep 30, 2025 | 47.51% |
| Jun 30, 2025 | 67.85% |
| Mar 31, 2025 | 19.06% |
| Dec 31, 2024 | 21.07% |
| Sep 30, 2024 | -38.05% |
| Jun 30, 2024 | -30.39% |
| Mar 31, 2024 | -30.99% |
| Dec 31, 2023 | 35.30% |
| Sep 30, 2023 | 26.27% |
| Jun 30, 2023 | 2.87% |
| Mar 31, 2023 | 1.98% |
| Dec 31, 2022 | -209.20% |
| Sep 30, 2022 | 24.40% |
| Jun 30, 2022 | -141.53% |
| Mar 31, 2022 | -89.09% |
| Dec 31, 2021 | -49.42% |
| Mar 31, 2021 | -276.36% |